Indexed keywords
CD34 ANTIGEN;
THALIDOMIDE;
ADULT;
AGED;
ARTICLE;
CHROMOSOME 11Q;
CHROMOSOME 13Q;
CHROMOSOME 17P;
CHROMOSOME ABERRATION;
CHROMOSOME DELETION 13;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYTOGENETICS;
DISEASE ASSOCIATION;
HUMAN;
HUMAN CELL;
MULTIPLE MYELOMA;
NEOVASCULARIZATION (PATHOLOGY);
PRIORITY JOURNAL;
PROGNOSIS;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
BONE MARROW;
CHROMOSOME DELETION;
CHROMOSOMES, HUMAN, PAIR 11;
CHROMOSOMES, HUMAN, PAIR 13;
CHROMOSOMES, HUMAN, PAIR 17;
GENETIC MARKERS;
HUMANS;
MICROCIRCULATION;
MIDDLE AGED;
MULTIPLE MYELOMA;
NEOVASCULARIZATION, PATHOLOGIC;
PROGNOSIS;
THALIDOMIDE;
2
0029124130
Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridisation
(1995)
Cancer Research
, vol.55
, pp. 3854-3859
Drach, J.1
Schuster, J.2
Nowotny, H.3
Angerler, J.4
Rosenthal, F.5
Fiegl, M.6
Rothermundt, C.7
Gsur, A.8
Jager, U.9
Heinz, R.10
Lechner, K.11
Ludwig, H.12
Huber, H.13
3
0032147210
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy
(1998)
Blood
, vol.92
, pp. 802-809
Drach, J.1
Ackermann, J.2
Fritz, E.3
Kromer, E.4
Schuster, R.5
Gisslinger, H.6
DeSantis, M.7
Zojer, N.8
Fiegl, M.9
Roka, S.10
Schuster, J.11
Heinz, R.12
Ludwig, H.13
Huber, H.14
4
0343049149
Predictive role of interphase cytogenetics for survival of patients with multiple myeloma
(2000)
Journal of Clinical Oncology
, vol.2000
, pp. 804-812
Konigsberg, R.1
Zojer, N.2
Ackermann, J.3
Kromer, E.4
Kittler, H.5
Fritz, E.6
Kaufmann, H.7
Nosslinger, T.8
Riedl, L.9
Gisslinger, H.10
Jager, U.11
Simonitsch, I.12
Heinz, R.13
Ludwig, H.14
Huber, H.15
Drach, J.16
5
0028408954
Why better prognostic factors for multiple myeloma are needed
(1994)
Blood
, vol.83
, pp. 1713-1716
Kyle, R.1
8
2642617778
Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes
(1998)
Blood
, vol.91
, pp. 3366-3371
Perez-Simon, J.A.1
Garcia-Sanz, R.2
Tabernero, M.D.3
Almeida, J.4
Gonzalez, M.5
Fernandez-Calvo, J.6
Moro, M.J.7
Hernandez, J.M.8
San Miguel, J.F.9
Orfao, A.10
10
0032903871
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma
(1999)
British Journal of Cancer
, vol.79
, pp. 451-455
Ribatti, D.1
Vacca, A.2
Nico, B.3
Quondamatteo, F.4
Ria, R.5
Minischetti, M.6
Marzullo, A.7
Herken, R.8
Roncali, L.9
Dammacco, F.10
11
7144255524
Prognostic value of cytogenetics in multiple myeloma
(1998)
British Journal of Haematology
, vol.101
, pp. 189-194
Seong, C.1
Delasalle, K.2
Hayes, D.3
Dimopoulos, M.4
Swantkowski, J.5
Huh, Y.6
Glassman, A.7
Champlin, R.8
Alexanian, R.9
12
0032748385
Marked anti-tumor effect from anti-angiogenesis therapy with thalidomide in high risk refractory multiple myeloma
(1999)
The New England Journal of Medicine
, vol.341
, pp. 1565-1571
Singhal, S.1
Mehta, J.2
Desikan, R.3
Ayers, D.4
Roberson, P.5
Eddlemon, P.6
Munshi, N.7
Anaissie, E.8
Wilson, C.9
Dhodapkar, M.10
Zeldis, J.11
Barlogie, B.12
13
0028880424
Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities
(1995)
Blood
, vol.86
, pp. 4250-4256
Tricot, G.1
Sawyer, J.2
Jagannath, S.3
Bracy, D.4
Mattox, S.5
Vesole, D.6
Naucke, S.7
Barlogie, B.8
14
17144433568
Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants
(1997)
Journal of Clinical Oncology
, vol.15
, pp. 2659-2666
Tricot, G.1
Sawyer, J.R.2
Jagannath, S.3
Desikan, K.R.4
Siegel, D.5
Naucke, S.6
Mattox, S.7
Bracy, D.8
Munshi, N.9
Barlogie, B.10
16
0033134764
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
(1999)
Blood
, vol.93
, pp. 3064-3073
Vacca, A.1
Ribatti, D.2
Presta, M.3
Minischetti, M.4
Iurlaro, M.5
Ria, R.6
Albini, A.7
Bussolino, F.8
Dammacco, F.9
17
17344395438
In multiple myeloma, deletion of 13q14 remains an independent adverse prognostic parameter despite its frequent detection by interphase FISH
(2000)
Blood
, vol.95
, pp. 1925-1930
Zojer, N.1
Konigsberg, R.2
Ackermann, J.3
Fritz, E.4
Dallinger, S.5
Kromer, E.6
Kaufmann, H.7
Riedl, L.8
Gisslinger, H.9
Schreiber, S.10
Heinz, R.11
Ludwig, H.12
Huber, H.13
Drach, J.14